UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 273

Sortiert nach

A unique subset of low-risk Wilms tumors is characterized by loss of function of TRIM28 (KAP1), a gene critical in early renal development: A Children's Oncology Group study

PloS one, 2018-12, Vol.13 (12), p.e0208936-e0208936

2018

Volltextzugriff (PDF)

Treatment decisions and the use of MEK inhibitors for children with neurofibromatosis type 1-related plexiform neurofibromas

BMC cancer, 2023-06, Vol.23 (1), p.553-553, Article 553

2023

Volltextzugriff (PDF)

SMART Syndrome (Stroke-Like Migraine Attacks After Radiation Therapy) in Adult and Pediatric Patients

Journal of child neurology, 2014-03, Vol.29 (3), p.336-341

2014

Volltextzugriff (PDF)

Genetic Characterization, Current Model Systems and Prognostic Stratification in PAX Fusion-Negative vs. PAX Fusion-Positive Rhabdomyosarcoma

Genes, 2021-09, Vol.12 (10), p.1500

2021

Volltextzugriff (PDF)

Late Effects in Pediatric High-risk Neuroblastoma Survivors After Intensive Induction Chemotherapy Followed by Myeloablative Consolidation Chemotherapy and Triple Autologous Stem Cell Transplants

Journal of pediatric hematology/oncology, 2018-01, Vol.40 (1), p.31-35

2018

Volltextzugriff (PDF)

Cell‐free DNA next‐generation sequencing successfully detects infectious pathogens in pediatric oncology and hematopoietic stem cell transplant patients at risk for invasive fungal disease

Pediatric blood & cancer, 2019-07, Vol.66 (7), p.e27734-n/a

2019

Volltextzugriff (PDF)

The Impact of High-resolution HLA-A, HLA-B, HLA-C, and HLA-DRB1 on Transplant-related Outcomes in Single-unit Umbilical Cord Blood Transplantation in Pediatric Patients

Journal of pediatric hematology/oncology, 2017-01, Vol.39 (1), p.26-32

2017

Volltextzugriff (PDF)

Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation

Human molecular genetics, 2019-08, Vol.28 (16), p.2752-2762

2019

Volltextzugriff (PDF)

Plexiform neurofibroma: shedding light on the investigational agents in clinical trials

Expert opinion on investigational drugs, 2022-01, Vol.31 (1), p.31-40

2022

Volltextzugriff (PDF)

A Systematic Review of Recent and Ongoing Clinical Trials in Patients With the Neurofibromatoses

Pediatric neurology, 2022-09, Vol.134, p.1-6

2022

Volltextzugriff (PDF)

Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG)

Neuro-oncology (Charlottesville, Va.), 2022-10, Vol.24 (10), p.1776-1789

2022

Volltextzugriff (PDF)

Lorlatinib use in an infant with thalamic ALK‐positive histiocytosis

Pediatric blood & cancer, 2023-09, Vol.70 (9), p.e30378-n/a

2023

Volltextzugriff (PDF)

Proximal Hypospadias and a Novel WT1 Variant: When Should Genetic Testing Be Considered?

Pediatrics (Evanston), 2018-04, Vol.141 (Suppl 5), p.S491

2018

Volltextzugriff (PDF)

Prolonged response to sorafenib in a patient with refractory metastatic osteosarcoma and a somatic PDGFRA D846V mutation

Pediatric blood & cancer, 2019-01, Vol.66 (1), p.e27493-n/a

2019

Volltextzugriff (PDF)

Cutaneous reactions to pediatric cancer treatment: Part I. Conventional chemotherapy

Pediatric dermatology, 2021-01, Vol.38 (1), p.8-17

2021

Volltextzugriff (PDF)

Advances in the clinical management of high‐risk Wilms tumors

Pediatric blood & cancer, 2023-05, Vol.70 (S2), p.e30342-n/a

2023

Volltextzugriff (PDF)

Advances in the clinical management of high‐risk Wilms tumors

Pediatric blood & cancer, 2023-03, Vol.70 (3), p.e30153-n/a

2023

Volltextzugriff (PDF)

Giant Cell Tumor of Rib Arising Anteriorly as a Large Inframammary Mass: A Case Report and Review of the Literature

Case Reports in Medicine, 2012-01, Vol.2012, p.850509-4

2012

Volltextzugriff (PDF)

Current Knowledge and Practice of Pediatric Providers in Umbilical Cord Blood Banking

Clinical pediatrics, 2018-02, Vol.57 (2), p.161-167

2018

Volltextzugriff (PDF)

Early administration of imatinib mesylate reduces plexiform neurofibroma tumor burden with durable results after drug discontinuation in a mouse model of neurofibromatosis type 1

Pediatric blood & cancer, 2020-08, Vol.67 (8), p.e28372-n/a

2020

Volltextzugriff (PDF)

Neurofibromatosis type 1-related tumours in paediatrics: an evolving treatment landscape

The lancet child & adolescent health, 2020-07, Vol.4 (7), p.488-490

2020

Volltextzugriff (PDF)

Loss of Chromosome 3q Is a Prognostic Marker in Fusion-Negative Rhabdomyosarcoma

JCO precision oncology, 2023-09, Vol.7, p.e2300037

2023

Volltextzugriff (PDF)

Peptides from cytomegalovirus UL130 and UL131 proteins induce high titer antibodies that block viral entry into mucosal epithelial cells

Vaccine, 2011-03, Vol.29 (15), p.2705-2711

2011

Volltextzugriff (PDF)

Irinotecan and temozolomide for treatment of neuroblastoma in a patient with renal failure on hemodialysis

Pediatric blood & cancer, 2014-05, Vol.61 (5), p.949-950

2014

Volltextzugriff (PDF)

1 – 25 von 273

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(252)
Mit Volltextzugriff
(238)

Publikationsform

Sprache

Englisch
(273)
Japanisch
(31)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

A unique subset of low-risk Wilms tumors is characterized by loss of function of TRIM28 (KAP1), a gene critical in early renal development: A Children's Oncology Group study

Treatment decisions and the use of MEK inhibitors for children with neurofibromatosis type 1-related plexiform neurofibromas

SMART Syndrome (Stroke-Like Migraine Attacks After Radiation Therapy) in Adult and Pediatric Patients

Genetic Characterization, Current Model Systems and Prognostic Stratification in PAX Fusion-Negative vs. PAX Fusion-Positive Rhabdomyosarcoma

Late Effects in Pediatric High-risk Neuroblastoma Survivors After Intensive Induction Chemotherapy Followed by Myeloablative Consolidation Chemotherapy and Triple Autologous Stem Cell Transplants

Cell‐free DNA next‐generation sequencing successfully detects infectious pathogens in pediatric oncology and hematopoietic stem cell transplant patients at risk for invasive fungal disease

The Impact of High-resolution HLA-A, HLA-B, HLA-C, and HLA-DRB1 on Transplant-related Outcomes in Single-unit Umbilical Cord Blood Transplantation in Pediatric Patients

Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation

Plexiform neurofibroma: shedding light on the investigational agents in clinical trials

Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial

A Systematic Review of Recent and Ongoing Clinical Trials in Patients With the Neurofibromatoses

Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG)

Lorlatinib use in an infant with thalamic ALK‐positive histiocytosis

Proximal Hypospadias and a Novel WT1 Variant: When Should Genetic Testing Be Considered?

Prolonged response to sorafenib in a patient with refractory metastatic osteosarcoma and a somatic PDGFRA D846V mutation

Cutaneous reactions to pediatric cancer treatment: Part I. Conventional chemotherapy

Advances in the clinical management of high‐risk Wilms tumors

Advances in the clinical management of high‐risk Wilms tumors

Giant Cell Tumor of Rib Arising Anteriorly as a Large Inframammary Mass: A Case Report and Review of the Literature

Current Knowledge and Practice of Pediatric Providers in Umbilical Cord Blood Banking

Early administration of imatinib mesylate reduces plexiform neurofibroma tumor burden with durable results after drug discontinuation in a mouse model of neurofibromatosis type 1

Neurofibromatosis type 1-related tumours in paediatrics: an evolving treatment landscape

Loss of Chromosome 3q Is a Prognostic Marker in Fusion-Negative Rhabdomyosarcoma

Peptides from cytomegalovirus UL130 and UL131 proteins induce high titer antibodies that block viral entry into mucosal epithelial cells

Irinotecan and temozolomide for treatment of neuroblastoma in a patient with renal failure on hemodialysis

Suchergebnisse filtern